<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50142">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02453438</url>
  </required_header>
  <id_info>
    <org_study_id>2014P001346</org_study_id>
    <nct_id>NCT02453438</nct_id>
  </id_info>
  <brief_title>Mood Patient Powered Research Network (MoodNetwork)</brief_title>
  <official_title>Mood Patient Powered Research Network (MoodNetwork)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The MoodNetwork, a patient-powered research network (PPRN), is one of 18 PPRNs participating
      in Patient-Centered Outcomes Research Institute's (PCORI) PCORnet network. Its objective is
      to improve the nation's capacity to conduct comparative effectiveness research that reflects
      questions of greatest importance to patients and other stakeholders. A robust data
      infrastructure will be built that, in phase one, allows participants to contribute data,
      including those from participant questionnaires, visualize their own health information in
      intuitive and helpful ways, and share their aggregated de-identified health information
      within and outside of the Network.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Patient Reported Outcomes Working Group Items Questionnaire</measure>
    <time_frame>average of 3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Composite International Diagnostic Interview Mania Questionnaire</measure>
    <time_frame>average of 3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mini International Neuropsychiatric Interview Depression</measure>
    <time_frame>average of 3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Quick Inventory of Depressive Symptoms Self Report</measure>
    <time_frame>average of 3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Altman Self Rated Mania Scale</measure>
    <time_frame>average of 3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>WHO-five well-being index (WHO-5)</measure>
    <time_frame>average of 3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Depression and Bipolar Support Alliance Wellness Tracker Questionnaire</measure>
    <time_frame>average of 3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Experience of Care and Health Outcomes Questionnaire</measure>
    <time_frame>average of 3 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50000</enrollment>
  <condition>Mood Disorders</condition>
  <condition>Bipolar Disorder</condition>
  <condition>Major Depressive Disorder</condition>
  <condition>Depression</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient Reported Outcomes</intervention_name>
    <description>Patient reported outcomes will be collected using a variety of questionnaires that assess mood symptoms.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        English speaking individuals over 18 years of age who self-identify as having a mood
        disorder.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English speaking

          -  Valid email address

          -  Self-identify as having a mood disorder

        Exclusion Criteria:

          -  Under 18 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew A Nierenberg, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samantha Walsh, B.S.</last_name>
    <phone>617-643-2076</phone>
    <email>moodnetwork@partners.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts General Hospital Bipolar Clinic and Research Program</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Walsh, B.S.</last_name>
      <phone>617-643-2076</phone>
      <email>moodnetwork@partners.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <lastchanged_date>June 22, 2016</lastchanged_date>
  <firstreceived_date>May 5, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Andrew A. Nierenberg, MD</investigator_full_name>
    <investigator_title>Director, Bipolar Clinic and Research Program</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
    <mesh_term>Mood Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
